Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Dengue vaccine poised for roll-out but safety concerns linger

Indonesia will be using the jab from next year, but some scientists say there are insufficient data to rule out that it could make infections worse in some people.
  1. Smriti Mallapaty

    1. Smriti Mallapaty is a senior reporter in Sydney, Australia.

    View author publications

    You can also search for this author in PubMed  Google Scholar

A vaccine to prevent infection from dengue — a mosquito-borne disease that kills 20,000 people a year — is poised to roll out in Indonesia next year. But the jab is stirring debate: some researchers say that important safety concerns have been overlooked.

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Learn more

Prices may be subject to local taxes which are calculated during checkout

Nature 611, 434-435 (2022)

doi: https://doi.org/10.1038/d41586-022-03546-2

Updates & Corrections

  • Correction 11 November 2022: A previous version of this story incorrectly stated that Qdenga was an inactivated-virus vaccine. It is a live attenuated vaccine.

References

  1. Biswal, S. et al. N. Engl. J. Med. 381, 2009–2019 (2019).

    Article  PubMed  Google Scholar 

  2. Halstead, S. B. J. Infect. Dis. 214, 1793–1795 (2016).

    Article  PubMed  Google Scholar 

  3. Sridhar, S. et al. N. Engl. J. Med. 379, 327–340 (2018).

    Article  PubMed  Google Scholar 

  4. Rivera, L. et al. Clin. Infect. Dis. 75, 107–117 (2022).

    Article  PubMed  Google Scholar 

Download references

Subjects

Latest on:

Nature Careers

Jobs

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing

Search

Advanced search

Quick links